MX2018008019A - Etiqueta de peptido y proteina etiquetada que incluye la misma. - Google Patents
Etiqueta de peptido y proteina etiquetada que incluye la misma.Info
- Publication number
- MX2018008019A MX2018008019A MX2018008019A MX2018008019A MX2018008019A MX 2018008019 A MX2018008019 A MX 2018008019A MX 2018008019 A MX2018008019 A MX 2018008019A MX 2018008019 A MX2018008019 A MX 2018008019A MX 2018008019 A MX2018008019 A MX 2018008019A
- Authority
- MX
- Mexico
- Prior art keywords
- peptide tag
- protein including
- tagged protein
- including same
- integer
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 3
- 108090000623 proteins and genes Proteins 0.000 title abstract 2
- 102000004169 proteins and genes Human genes 0.000 title abstract 2
- 125000000539 amino acid group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
- C07K14/39—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
- C07K14/43563—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/461—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from fish
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/565—IFN-beta
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/61—Growth hormone [GH], i.e. somatotropin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K4/00—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2477—Hemicellulases not provided in a preceding group
- C12N9/248—Xylanases
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/50—Fusion polypeptide containing protease site
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/60—Fusion polypeptide containing spectroscopic/fluorescent detection, e.g. green fluorescent protein [GFP]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2531/00—Reactions of nucleic acids characterised by
- C12Q2531/10—Reactions of nucleic acids characterised by the purpose being amplify/increase the copy number of target nucleic acid
- C12Q2531/113—PCR
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Mycology (AREA)
- Endocrinology (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Insects & Arthropods (AREA)
- Immunology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
Un péptido que comprende la secuencia mostrada enseguida se adiciona como una etiqueta de péptido a una proteína útil, seguida por permitir su expresión. Xm(PYn)qPZr En esta fórmula, X, Y y Z cada uno representa un residuo de aminoácido independientemente seleccionado del grupo que consiste de R, G, S, K, T, L, N, Q y H, con la condición de que por lo menos un Y represente K, L, N, Q, H o R. m representa un número entero de 0 a 5; n representa 1, 2 o 3; q representa un número entero de 1 a 10 y r representa un número entero de 0 a 10.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2015256396 | 2015-12-28 | ||
JP2016153265 | 2016-08-03 | ||
PCT/JP2016/089139 WO2017115853A1 (ja) | 2015-12-28 | 2016-12-28 | ペプチドタグおよびそれを含むタグ付加タンパク質 |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2018008019A true MX2018008019A (es) | 2018-11-09 |
Family
ID=59225307
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2018008019A MX2018008019A (es) | 2015-12-28 | 2016-12-28 | Etiqueta de peptido y proteina etiquetada que incluye la misma. |
Country Status (11)
Country | Link |
---|---|
US (2) | US10808253B2 (es) |
EP (1) | EP3399033A4 (es) |
JP (2) | JP7027168B2 (es) |
KR (1) | KR20180091098A (es) |
CN (1) | CN108473979B (es) |
AU (1) | AU2016382134B2 (es) |
BR (1) | BR112018013246A2 (es) |
CA (1) | CA3009880A1 (es) |
MX (1) | MX2018008019A (es) |
TW (1) | TW201726706A (es) |
WO (1) | WO2017115853A1 (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017217460A1 (ja) * | 2016-06-15 | 2017-12-21 | 出光興産株式会社 | ペプチドリンカーで連結された2以上のタンパク質を含む融合タンパク質 |
JP2019146524A (ja) * | 2018-02-27 | 2019-09-05 | 出光興産株式会社 | 高発現かつ高機能な二重特異性抗体 |
CN112639103A (zh) * | 2018-08-31 | 2021-04-09 | 出光兴产株式会社 | 利用肽标签的蛋白质可溶性表达 |
CN109182299B (zh) * | 2018-10-30 | 2021-12-31 | 福建师范大学 | 耐受过氧化氢的枯草芽胞杆菌脂肪酶突变体及其制备方法 |
US20240002896A1 (en) * | 2020-10-27 | 2024-01-04 | Idemitsu Kosan Co.,Ltd. | Peptide tag and tagged protein containing same |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5273438A (en) | 1975-12-15 | 1977-06-20 | Tomita Takahashi | Folding structure of truck handle |
JPS5818558B2 (ja) | 1976-11-13 | 1983-04-13 | 株式会社クボタ | 流量圧力制御方法 |
US6686333B1 (en) * | 1996-10-04 | 2004-02-03 | The United States Of America As Represented By The Department Of Health And Human Resources | Inhibition of HIV replication using soluble Tat peptide analogs |
ES2338097T3 (es) * | 2000-04-14 | 2010-05-04 | Genencor International, Inc. | Procedimiento de identificacion selectiva. |
US7205387B2 (en) * | 2003-08-28 | 2007-04-17 | Agency For Science, Technology And Research | Recombinant polypeptide useful for neurotrophin receptor mediated gene delivery and as neurotrophin agonist |
US20100234568A1 (en) * | 2006-10-19 | 2010-09-16 | Linda Jane Decarolis | Identification of peptide tags for the production of insoluble peptides by sequence scanning |
US20090137004A1 (en) * | 2007-11-15 | 2009-05-28 | Molecular Kinetics Incorporated | Artificial entropic bristle domain sequences and their use in recombinant protein production |
JP5273438B2 (ja) | 2007-11-22 | 2013-08-28 | 国立大学法人東京農工大学 | ペプチド付加生体分子の溶解度計算方法、及びそれを用いたペプチドタグの設計方法と封入体形成防止方法 |
JP2009201437A (ja) * | 2008-02-28 | 2009-09-10 | Toyota Motor Corp | 種子内の油脂含量を調節する変異遺伝子、種子内油脂含量の調節方法 |
EP2287300B1 (en) * | 2008-05-02 | 2018-06-27 | Idemitsu Kosan Co., Ltd. | Bacterial toxin vaccine |
JP5626717B2 (ja) * | 2009-03-26 | 2014-11-19 | 学校法人日本大学 | レチノイン酸受容体αを含む融合タンパク質 |
WO2010129033A2 (en) * | 2009-04-29 | 2010-11-11 | Calmune Corporation | Modified antibodies for passive immunotherapy |
WO2013091661A2 (en) * | 2011-12-23 | 2013-06-27 | Aarhus Universitet | Proteolytic resistant protein affinity tag |
MX366864B (es) * | 2012-02-27 | 2019-07-26 | Amunix Operating Inc | Composiciones de conjugados de xten y métodos para realizarlas. |
EP2897631A4 (en) | 2012-08-31 | 2016-10-05 | Univ Virginia Patent Found | TARGET PEPTIDES FOR IMMUNOTHERAPY AND DIAGNOSIS |
ES2732291T3 (es) * | 2013-05-02 | 2019-11-21 | Glaxosmithkline Ip Dev Ltd | Péptidos terapéuticos |
-
2016
- 2016-12-28 EP EP16881827.6A patent/EP3399033A4/en active Pending
- 2016-12-28 KR KR1020187020935A patent/KR20180091098A/ko unknown
- 2016-12-28 WO PCT/JP2016/089139 patent/WO2017115853A1/ja active Application Filing
- 2016-12-28 CN CN201680076564.0A patent/CN108473979B/zh active Active
- 2016-12-28 CA CA3009880A patent/CA3009880A1/en active Pending
- 2016-12-28 AU AU2016382134A patent/AU2016382134B2/en active Active
- 2016-12-28 BR BR112018013246-2A patent/BR112018013246A2/pt active Search and Examination
- 2016-12-28 US US16/066,468 patent/US10808253B2/en active Active
- 2016-12-28 JP JP2017559238A patent/JP7027168B2/ja active Active
- 2016-12-28 TW TW105143577A patent/TW201726706A/zh unknown
- 2016-12-28 MX MX2018008019A patent/MX2018008019A/es unknown
-
2020
- 2020-09-11 US US17/018,751 patent/US20210130404A1/en active Pending
-
2021
- 2021-12-23 JP JP2021209816A patent/JP2022044600A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
CN108473979B (zh) | 2022-08-19 |
JP2022044600A (ja) | 2022-03-17 |
EP3399033A1 (en) | 2018-11-07 |
AU2016382134A1 (en) | 2018-07-26 |
TW201726706A (zh) | 2017-08-01 |
AU2016382134B2 (en) | 2022-09-22 |
KR20180091098A (ko) | 2018-08-14 |
US20210130404A1 (en) | 2021-05-06 |
JPWO2017115853A1 (ja) | 2018-10-18 |
US10808253B2 (en) | 2020-10-20 |
CN108473979A (zh) | 2018-08-31 |
JP7027168B2 (ja) | 2022-03-01 |
US20190024094A1 (en) | 2019-01-24 |
CA3009880A1 (en) | 2017-07-06 |
EP3399033A4 (en) | 2019-06-19 |
BR112018013246A2 (pt) | 2018-12-04 |
WO2017115853A1 (ja) | 2017-07-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2018008019A (es) | Etiqueta de peptido y proteina etiquetada que incluye la misma. | |
MX2020004578A (es) | Composiciones de casz y metodos de uso. | |
UA120917C2 (uk) | Химерний білок фактора viii та його застосування | |
CL2020001262A1 (es) | Plataforma de presentación en endosporas basadas en paenibacillus, productos y métodos relacionados. | |
PH12020550051A1 (en) | Glp-1 compositions and uses thereof | |
EA201691794A1 (ru) | Конденсированные [1,4]диазепиновые соединения в качестве ингибиторов продукции аутотаксина (atx) и лизофосфатидиловой кислоты (lpa) | |
WO2015015448A3 (en) | Engineered polypeptide conjugates using transglutaminase | |
UA118167C2 (uk) | Пептид та його застосування | |
MX2020006612A (es) | Compuesto que funciona como inhibidor de proteína de bromodominio y composición. | |
MX2016011394A (es) | Moleculas de andamiaje a base de fibronectina estabilizada. | |
WO2015179635A3 (en) | Ras inhibitory peptides and uses thereof | |
WO2016130628A8 (en) | Griffithsin mutants | |
WO2017091734A3 (en) | Bacteriocidal peptides and uses thereof | |
PH12017502323A1 (en) | Novel xylanase | |
MX2017010359A (es) | Cadena alfa del receptor de inmunoglobulina e (ige) de alta afinidad de fusion de fragmento cristalizable (fc). | |
MX2023005421A (es) | Composiciones de proteina anti-vegf y metodos para producir la misma. | |
BR112016026842A2 (pt) | preparação compreendendo fator viii e peptídeos de fator de von willebrand | |
EP3977739A4 (en) | REORGANIZATION OF MERGER CANDIDATES ACCORDING TO A GLOBAL MOTION VECTOR CROSS-REFERENCE TO RELATED APPLICATIONS | |
IL283430B (en) | Formulations that include recombinant acid alpha-glucosidase | |
PH12021551055A1 (en) | Klk5 inhibitory peptide | |
MX2018000023A (es) | Particulas semejantes a virus recombinantes que utilizan la proteina gag del virus de inmunodeficiencia bovina. | |
WO2017002049A3 (en) | Conserved chaperone domain for type vi secretion system | |
MX2018014490A (es) | Peptido antimicrobiano modificado derivado de un dominio rico en arginina. | |
WO2018170236A9 (en) | CDPK1 INHIBITORS, COMPOSITIONS AND RELATED METHODS | |
EA201891717A1 (ru) | Препараты мультигеномных ретровирусных векторов и способы и системы для их получения и применения |